A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade
Sahil Sahni(National Institutes of Health), Eytan Ruppin(National Institutes of Health), Sushant Patkar(National Institutes of Health), Matthew Nagy(National Institutes of Health), Saugato Rahman Dhruba(National Institutes of Health), Binbin Wang(National Institutes of Health), Di Wu(National Institutes of Health), Kun Wang(University of Illinois Urbana-Champaign), Chi-Ping Day(National Institutes of Health), Ingrid Ferreira(Wellcome Sanger Institute)
Cited by 14
Related Papers
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
|Nature Communications|2020|156